Novartis Signs $150M Deal with Schrödinger to Advance Drug Discovery Programs
Pharmaceutical giant Novartis has entered a strategic partnership with Schrödinger, paying $150 million for access to the company's innovative drug ...
Tag: Drug Discovery Programs
